http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2016016419-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89a6bd4a27bd6c2955f6a169fe0cb689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aecc858af3148332ea7d3579cb3f084c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28cbf1d993ef2e41dbba532b939078ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7aeca392c7b281e1c63f7bcb4589ff7
publicationDate 2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2016016419-A
titleOfInvention CONJUGATES AND COMPOSITIONS OF TEXAFIRINA-PT (IV) FOR USE TO EXCEED THE RESISTANCE OF THE PLATINUM.
abstract The present description relates to conjugates linked to platinum (IV) and texaphyrin and compositions comprising texaphyrin and a platinum (IV) agent. The present description also provides pharmaceutical compositions of said conjugates and compositions. Also, methods of using the present compounds in the treatment of cancer such as platinum resistant cancer are provided.
priorityDate 2014-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939

Total number of triples: 32.